[go: up one dir, main page]

Pervez et al., 2024 - Google Patents

CORRELATION OF HISTOLOGICAL SPECTRUM OF HYSTERECTOMY SPECIMENS WITH CLINICAL DIAGNOSIS. A MULTI-CENTRIC STUDY

Pervez et al., 2024

View PDF
Document ID
4269277042722971076
Author
Pervez S
Naz S
Muhammad A
Balooch F
Ahmad M
Ismail N
Publication year
Publication venue
Khyber Journal of Medical Sciences

External Links

Snippet

Objective: To investigate the relationship between the histological spectrum of hysterectomy specimens and preoperative clinical diagnosis. Methodology: From January 2020 to December 2023, three major medical centers—MTI Hayatabad Medical Complex, Kabir …
Continue reading at kjms.com.pk (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57442—Specifically defined cancers of the uterus and endometrial
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57411—Specifically defined cancers of cervix
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads

Similar Documents

Publication Publication Date Title
Kolhe Management of abnormal uterine bleeding–focus on ambulatory hysteroscopy
Kil et al. Usefulness of CA125 in the differential diagnosis of uterine adenomyosis and myoma
Krentel et al. Prevalence of adenomyosis in women undergoing hysterectomy for abnormal uterine bleeding, pelvic pain or uterine prolapse–A retrospective cohort study
Nguyen Evaluating clinical features in intracavitary uterine pathologies among Vietnamese women presenting with peri-and postmenopausal bleeding: a bicentric observational descriptive analysis
Khaniki et al. Histopathological study of hysterectomy operations in a University clinic in Tehran from 2005 to 2009
Vilos et al. Histopathology and clinical outcomes of 151 women with postmenopausal bleeding treated with resectoscopic surgery
McGowan et al. Does the presence of single compared to multiple endometrial polyps alter the risk of cancer in post-menopausal women?
Sumtsov et al. Practical means of preoperative diagnostics of primary fallopian tube cancer
Akbari Sene et al. Diagnostic value and agreement of transrectal in comparison with transvaginal sonography among women with abnormal uterine bleeding
Dermawan et al. Thickened endometrium in postmenopausal women with an initial biopsy of limited, benign, surface endometrium: clinical outcome and subsequent pathologic diagnosis
Yilmaz et al. Incidence of occult malignancies identified during hysterectomies performed for benign indications
Tehranian et al. Evaluation of women presenting with postcoital bleeding by cytology and colposcopy
Pervez et al. CORRELATION OF HISTOLOGICAL SPECTRUM OF HYSTERECTOMY SPECIMENS WITH CLINICAL DIAGNOSIS. A MULTI-CENTRIC STUDY
Patel et al. Histopathological analysis of hysterectomy specimens in tertiary care center: two-year study
Díaz de la Noval et al. Transvaginal Ultrasound‐Guided Fine‐Needle Aspiration of Adnexal Cysts With a Low Risk of Malignancy: Our Experience and Recommendations
Radwan et al. Detection of intracavitary lesions in 820 infertile women: comparison of outpatient hysteroscopy with histopathological examination
Mohamed et al. Role of diagnostic hysteroscopy in cases with unexplained infertility
Alrawi et al. Comparison between ultrasound and hysteroscopy in the diagnosis of intra-uterine space-occupying lesion in Tikrit teaching hospital
Şahin et al. Evaluation of colposcopy and LEEP results performed in gynecology and gynecological oncology surgery services.
Qureshi et al. Endometrial hyperplasia in Indian perimenopausal women: A retrospective analysis
Antunes The efficacy of hysteroscopy in diagnosis and treatment of endometrial pathology
Diallo et al. Endometrial hyperplasia: epidemiological profile of patients and anatomical and clinical aspects of lesions at Conakry University hospital
El-Demiry et al. Accuracy of 3D Ultrasound in the Diagnosis of Uterine Pathology in Patients with Postmenopausal Bleeding.
Şahin et al. Evaluation of colposcopy and LEEP results performed in gynecology and gynecological oncology surgery services
Gawron et al. Occult uterine malignancy during laparoscopic supracervical hysterectomy